Crystal structure of a transcriptionally active Smad4 fragment

被引:60
作者
Qin, B [1 ]
Lam, SSW [1 ]
Lin, K [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Pharmacol & Mol Toxicol, Worcester, MA 01655 USA
关键词
phosphorylation; signal transduction; SMAD; TGF-beta; transcription;
D O I
10.1016/S0969-2126(00)88340-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Smad4 functions as a common mediator of transforming growth factor beta (TGF-beta) signaling by forming complexes with the phosphorylated state of pathway-restricted SMAD proteins that act in specific signaling pathways to activate transcription. SMAD proteins comprise two domains, the MH1 and MH2 domain, separated by a linker region. The transcriptional activity and synergistic effect of Smad4, require a stretch of proline-rich sequence, the SMAD-activation domain (SAD), located N-terminal of the MH2 domain. To understand how the SAD contributes to Smad4 function, the crystal structure of a fragment including the SAD and MH2 domain (S4AF) was determined. Results: The structure of the S4AF trimer reveals novel features important for Smad4 function. A Smad4-specific sequence insertion within the MH2 domain interacts with the C-terminal tail to form a structural extension from the core. This extension (the TOWER) contains a solvent-accessible glutamine-rich helix. The SAD reinforces the TOWER and the structural core through interactions; two residues involved in these interactions are targets of tumorigenic mutation. The solvent-accessible proline residues of the SAD are located on the same face as the glutamine-rich helix of the TOWER, forming a potential transcription activation surface. A tandem sulfate-ion-binding site was identified within the subunit interface, which may interact with the phosphorylated C-terminal sequence of pathway-restricted SMAD proteins. Conclusions: The structure suggests that the SAD provides transcriptional capability by reinforcing the structural core and coordinating with the TOWER to present the proline-rich and glutamine-rich surfaces for interaction with transcription partners. The sulfate-ion-binding sites are potential 'receptors' for the phosphorylated sequence of pathway-restricted SMAD proteins in forming a heteromeric complex. The structure thus provides a new model that can be tested using biochemical and cellular approaches.
引用
收藏
页码:1493 / 1503
页数:11
相关论文
共 52 条
[21]   MOLSCRIPT - A PROGRAM TO PRODUCE BOTH DETAILED AND SCHEMATIC PLOTS OF PROTEIN STRUCTURES [J].
KRAULIS, PJ .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1991, 24 :946-950
[22]   FUNCTIONAL DIFFERENCES BETWEEN MAMMALIAN TRANSCRIPTION ACTIVATION DOMAINS AT THE YEAST GAL1 PROMOTER [J].
KUNZLER, M ;
BRAUS, GH ;
GEORGIEV, O ;
SEIPEL, K ;
SCHAFFNER, W .
EMBO JOURNAL, 1994, 13 (03) :641-645
[23]   Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain [J].
Kussie, PH ;
Gorina, S ;
Marechal, V ;
Elenbaas, B ;
Moreau, J ;
Levine, AJ ;
Pavletich, NP .
SCIENCE, 1996, 274 (5289) :948-953
[24]   Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways [J].
Lagna, G ;
Hata, A ;
HemmatiBrivanlou, A ;
Massague, J .
NATURE, 1996, 383 (6603) :832-836
[25]  
Lei JY, 1996, ONCOGENE, V13, P2459
[26]   A human Mad protein acting as a BMP-regulated transcriptional activator [J].
Liu, F ;
Hata, A ;
Baker, JC ;
Doody, J ;
Carcamo, J ;
Harland, RM ;
Massague, J .
NATURE, 1996, 381 (6583) :620-623
[27]   Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas [J].
MacGrogan, D ;
Pegram, M ;
Slamon, D ;
Bookstein, R .
ONCOGENE, 1997, 15 (09) :1111-1114
[28]   TGF beta signaling: Receptors, transducers, and mad proteins [J].
Massague, J .
CELL, 1996, 85 (07) :947-950
[29]  
Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X
[30]   RASTER3D VERSION-2.0 - A PROGRAM FOR PHOTOREALISTIC MOLECULAR GRAPHICS [J].
MERRITT, EA ;
MURPHY, MEP .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :869-873